# AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

> **NCT00343408** · PHASE1 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 31 (actual)

## Conditions studied

- Colorectal Cancer
- Lung Cancer

## Interventions

- **DRUG:** cediranib maleate
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00343408
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-29
- **Primary completion:** 2007-09-18
- **Final completion:** 2008-09-22
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343408, "AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00343408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*